9/21/2025

Kenvue Inc. (NYSE:KVUE) is included among the 10 Best NYSE Dividend Stocks to Buy. Kenvue Inc. (NYSE:KVUE) produces and sells consumer health products across several categories, including over-the-counter medicines, personal care, and wellness items. Its portfolio features well-known household brands such as Tylenol for pain and fever relief, Neutrogena for skin care, and Listerine for oral […]

Source: Yahoo

9/20/2025

Kenvue Inc. (NYSE:KVUE) is a consumer health company that offers well-known brands in categories like pain management, skin and beauty, oral care, and cough, cold, and allergy care, including brands like Tylenol, Listerine, and Neutrogena. It will ...

Source: Yahoo

9/19/2025

MSFT, JNJ, NKE and SPGI use strong moats to fend off rivals and deliver consistent returns amid market shifts.

Source: Yahoo

9/18/2025

Harris Associates’ 13F portfolio rose to $61.5B in Q2 2025. Read here for insights on Q2 2025 portfolio trends, top stock moves, and bullish picks.

Source: SeekingAlpha

9/15/2025

(Updates with response from the Department of Health and Human Services in the fifth and sixth parag

Source: Yahoo

9/12/2025

↗️ Alibaba (HK:9988), (BABA): The Chinese technology company released its latest AI model and said it would issue convertible bonds to help fund cloud infrastructure. Shares jumped 5.4% in Hong Kong. ↗️ Microsoft (MSFT): OpenAI and Microsoft reached a deal to extend their partnership, capping a summer of difficult negotiations.

Source: Yahoo

9/12/2025

Health Care Down on Regulatory Fears -- Health Care Roundup

Source: MarketWatch

9/12/2025

The Dow Jones Industrial Average was down, while the S&P 500 and Nasdaq Composite were up in late-mo

Source: Yahoo

9/12/2025

Sixteen of the thirty-eight highest-yield, 'safer' S&P 500 dividend stocks are highlighted as ready to buy, with adequate free cash flow supporting payouts. Read more here.

Source: SeekingAlpha

9/12/2025

Kenvue's (KVUE) interim chief executive Kirk Perry had a private meeting with Robert F Kennedy Jr. t

Source: Yahoo

9/12/2025

WSJ reported on September 5 that the U.S. health secretary planned to announce that the use of Tylenol, a popular over-the-counter pain medication, in pregnant women was potentially linked to autism - contrary to medical guidelines that say it is safe to use. As we would with any regulator who reaches out to us, we engaged in a scientific exchange with the secretary and members of his staff as it relates to the safety of our products, Kenvue said in an emailed response. The company said it continues to believe that taking acetaminophen - the active ingredient in Tylenol - does not cause autism and that global health regulators, independent public health organizations and medical professionals agreed.

Source: Yahoo

9/12/2025

In a hastily scheduled meeting, Kenvue interim Chief Executive Kirk Perry sought to dissuade the health secretary, arguing there is no clear link.

Source: Yahoo

9/11/2025

Kenvue Inc. stock rises Thursday, outperforms market

Source: MarketWatch

9/11/2025

Despite Kenvue’s recent underperformance relative to the Dow, analysts remain moderately optimistic about the stock’s prospects.

Source: Yahoo

9/10/2025

Kenvue Inc. stock falls Wednesday, underperforms market

Source: MarketWatch

9/10/2025

If you have been watching Kenvue (KVUE) lately, there is a good chance the news has caught your attention. A series of high-profile reports suggest that federal health officials, including Health Secretary RFK Jr., may soon associate the use of Tylenol during pregnancy with autism. This potential warning is stirring investor anxiety, not just because Tylenol is a flagship product but also due to the ripple effect such health concerns can have on market sentiment. The fallout has been swift,...

Source: Yahoo

9/10/2025

We review the top Dividend Kings offering strong yields and fair value. See which stocks stand out for safer dividends and growth potential this September.

Source: SeekingAlpha

9/9/2025

Canaccord Genuity went on social media to gauge the reaction. Even the MAHA crowd was mixed on this one.

Source: Yahoo

9/9/2025

Kenvue Inc. stock rises Tuesday, outperforms market

Source: MarketWatch

9/9/2025

Tech sector gains masked the underperforming stocks in the S&P 500; selective buying and holding is recommended based on company-specific factors. Read the full analysis here.

Source: SeekingAlpha